I’m on the same page, the timeline isn’t as critical as getting the validation trial right. If that goes well, the rest should fall into place, including FDA approval and eventual commercialisation. Even if it takes a couple of years, it’ll be worth the wait.
You’re spot on about management too. They’ve played things smart, keeping things lean while pushing towards commercialisation. The idea of this tech becoming a new major imaging method alongside Ultrasound, CT, and MRI is exciting. Lots to look forward to!
- Forums
- ASX - By Stock
- EMV
- EMvision Research Notes
EMvision Research Notes, page-2615
-
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.08 |
Change
-0.010(0.48%) |
Mkt cap ! $177.8M |
Open | High | Low | Value | Volume |
$2.09 | $2.14 | $2.06 | $68.41K | 32.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 379 | $2.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.10 | 250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 379 | 2.080 |
2 | 5690 | 2.060 |
1 | 1500 | 2.050 |
4 | 8000 | 2.000 |
1 | 350 | 1.985 |
Price($) | Vol. | No. |
---|---|---|
2.100 | 250 | 1 |
2.110 | 10000 | 1 |
2.150 | 7000 | 1 |
2.200 | 14000 | 2 |
2.220 | 18000 | 1 |
Last trade - 13.07pm 21/10/2024 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online